DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE
DILTIAZEM HYDROCHLORIDE
Approval overview DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE is listed in Drugs@FDA under application 218038 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DILTIAZEM HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - 250MG/250ML (1MG/ML) Sponsor HQ SPCLT PHARMA Submission history Latest submission status date: 2025-02-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE is listed in Drugs@FDA under application 218038 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DILTIAZEM HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - 250MG/250ML (1MG/ML) Sponsor HQ SPCLT PHARMA Submission history Latest submission status date: 2025-02-21 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.